Option Chain

Boston Scientific Corp

BSXNYSE · USD

42.75USD-1.89 (-4.24%)

372

Boston Scientific Corp (BSX) Option Chain

Boston Scientific Corp trades at $42.75, down 4.24%, with an IV Rank of 59.92%. This is average versus the past year, and the company carries a market cap of $64,704M in the Medical Devices industry. On the Nov 13, 2026 chain, the at the money $42.50 strike shows calls at $2.15 / $2.75 and puts at $0.25 / $0.55, both carrying about $1.30 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $44.50 calls, at 124 contracts, and the $40.00 puts, at 10, as of Nov 5, 2026.

Tracking the BSX option chain helps you see every strike and expiry on Boston Scientific Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of BSX options activity at a glance. Use our scanner to monitor the BSX option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For BSX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where BSX options are being actively traded, and where they are not.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
10.80	19	0	2.10	1.25	2.60	4.10	41.50	-7.03	0.05	0.55	0.00	0.30	4	117	89.20
15.11	378	0	2.00	0.75	2.30	3.20	42.00	-5.91	0.20	0.45	0.00	0.33	6	945	84.89
20.37	47	0	2.20	0.25	2.15	2.75	42.50	-4.79	0.25	0.55	0.00	0.40	0	79	79.63
26.51	89	0	2.10	0.00	1.90	2.30	43.00	-3.67	0.45	0.90	0.25	0.43	5	253	73.49
33.38	236	6	1.80	0.00	1.55	2.05	43.50	-2.55	0.60	0.85	0.75	-0.03	0	44	66.62

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryMedical Devices
SectorHealthcare
IV Rank59.92% Moderate
Market cap (M$)64,704
52 weeks high-57.75%
52 weeks low12.81%
Analyst recommendationBuy
1.79
Target price$50.48
23.20% above the current stock price
Dividend—
Payout ratio0.00%
Earnings date2027-02-03
P/E18.90
Future P/E14.27
EPS (ttm)2.36
EPS growth next 5 years3.23%

As of Nov 5, 2026

Browse all Option Chain tickers